author-photo

Henrik Klitgaard

UCB

101

Papers

5230

Citations

Citation Trend

Filter By

Papers (70) Sort By

Journal Conference Others

Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review.

2021 Epilepsy & Behavior
Show All
- Source
- Cite
- Save
Citations (3)
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?

2020 Epilepsia
Show All
- Source
- Cite
- Save
Citations (20)
A Team Science Approach to Discover Novel Targets for Infantile Spasms (IS)

2020
Show All
- Source
- Cite
- Save
Citations (1)
A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.

2019 Epilepsia
Show All
- Source
- Cite
- Save
Citations (23)
Pharmacological profile of the antiepileptic drug candidate padsevonil – characterization in rodent seizure and epilepsy models

2019 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (12)
Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

2018 Epilepsia
Show All
- Source
- Cite
- Save
Citations (119)
Brivaracetam enters the brain faster than levetiracetam: a PET study in healthy volunteers (P6.233)

2017 Neurology
Show All
- Source
- Cite
- Save
Citations (5)
Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus

2017 Epilepsia
Show All
- Source
- Cite
- Save
Citations (21)
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond

2016 CNS Drugs
Show All
- Source
- Cite
- Save
Citations (74)
Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.

2016 Epilepsia
Show All
- Source
- Cite
- Save
Citations (97)